$7.26
00.00%
Pre-Market: Jul 19, 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Health Catalyst
HCATNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Health Catalyst (NASDAQ:HCAT) Stock, Analyst Ratings, Price Targets, Forecasts
Health Catalyst Inc has a consensus price target of $17.38 based on the ratings of 18 analysts. The high is $55 issued by Citigroup on December 20, 2021. The low is $8 issued by Evercore ISI Group on July 9, 2024. The 3 most-recent analyst ratings were released by Evercore ISI Group, Piper Sandler, and Canaccord Genuity on July 9, 2024, June 6, 2024, and May 21, 2024, respectively. With an average price target of $11 between Evercore ISI Group, Piper Sandler, and Canaccord Genuity, there's an implied 51.52% upside for Health Catalyst Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Evercore ISI Group
Piper Sandler
Canaccord Genuity
Wells Fargo
Cantor Fitzgerald
1calculated from analyst ratings
Analyst Ratings for Health Catalyst
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/09/2024 | Buy Now | 10.19% | Evercore ISI Group | Elizabeth Anderson | $9 → $8 | Maintains | Outperform | Get Alert |
| 06/06/2024 | Buy Now | 92.84% | Piper Sandler | Jessica Tassan | $15 → $14 | Maintains | Overweight | Get Alert |
| 05/21/2024 | Buy Now | 51.52% | Canaccord Genuity | Richard Close | $11 → $11 | Maintains | Buy | Get Alert |
| 05/10/2024 | Buy Now | 79.06% | Wells Fargo | Stan Berenshteyn | $14 → $13 | Maintains | Overweight | Get Alert |
| 04/10/2024 | Buy Now | 120.39% | Cantor Fitzgerald | Sarah James | → $16 | Reiterates | Overweight → Overweight | Get Alert |
| 04/10/2024 | Buy Now | — | Keybanc | Scott Schoenhaus | — | Downgrade | Overweight → Sector Weight | Get Alert |
| 03/05/2024 | Buy Now | 120.39% | Cantor Fitzgerald | Sarah James | → $16 | Reiterates | Overweight → Overweight | Get Alert |
| 02/26/2024 | Buy Now | 37.74% | Keybanc | Scott Schoenhaus | $12 → $10 | Maintains | Overweight | Get Alert |
| 02/23/2024 | Buy Now | 106.61% | Piper Sandler | Jessica Tassan | $17 → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 02/23/2024 | Buy Now | 37.74% | Evercore ISI Group | Elizabeth Anderson | $11 → $10 | Maintains | Outperform | Get Alert |
| 02/23/2024 | Buy Now | 51.52% | Canaccord Genuity | Richard Close | $12 → $11 | Maintains | Buy | Get Alert |
| 01/26/2024 | Buy Now | 92.84% | Guggenheim | Jack Wallace | → $14 | Upgrade | Neutral → Buy | Get Alert |
| 01/03/2024 | Buy Now | 51.52% | Evercore ISI Group | Elizabeth Anderson | $9 → $11 | Upgrade | In-Line → Outperform | Get Alert |
| 12/22/2023 | Buy Now | 65.29% | Piper Sandler | Jessica Tassan | $11 → $12 | Maintains | Overweight | Get Alert |
| 12/13/2023 | Buy Now | 51.52% | JP Morgan | Anne Samuel | $14 → $11 | Upgrade | Neutral → Overweight | Get Alert |
| 11/13/2023 | Buy Now | 51.52% | Piper Sandler | Jessica Tassan | $12 → $11 | Upgrade | Neutral → Overweight | Get Alert |
| 11/01/2023 | Buy Now | 65.29% | Stifel | David Grossman | $15 → $12 | Maintains | Hold | Get Alert |
| 10/30/2023 | Buy Now | 10.19% | RBC Capital | Sean Dodge | $13 → $8 | Maintains | Sector Perform | Get Alert |
| 09/14/2023 | Buy Now | 120.39% | Cantor Fitzgerald | Steven Halper | → $16 | Reiterates | Overweight → Overweight | Get Alert |
| 08/29/2023 | Buy Now | 92.84% | Canaccord Genuity | Richard Close | $16 → $14 | Maintains | Buy | Get Alert |
| 08/01/2023 | Buy Now | 120.39% | Cantor Fitzgerald | Steven Halper | → $16 | Initiates | Overweight → Overweight | Get Alert |
| 05/10/2023 | Buy Now | 79.06% | RBC Capital | Sean Dodge | $15 → $13 | Maintains | Sector Perform | Get Alert |
| 05/10/2023 | Buy Now | — | Raymond James | John Ransom | — | Downgrade | Strong Buy → Market Perform | Get Alert |
| 05/10/2023 | Buy Now | — | Guggenheim | Jack Wallace | — | Downgrade | Buy → Hold | Get Alert |
| 04/20/2023 | Buy Now | 120.39% | Keybanc | Scott Schoenhaus | → $16 | Upgrade | Sector Weight → Overweight | Get Alert |
| 04/04/2023 | Buy Now | 120.39% | Wells Fargo | Stan Berenshteyn | $13 → $16 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 03/24/2023 | Buy Now | 120.39% | Citigroup | Daniel Grosslight | $17 → $16 | Maintains | Buy | Get Alert |
| 03/08/2023 | Buy Now | 134.16% | Citigroup | Daniel Grosslight | $16 → $17 | Maintains | Buy | Get Alert |
| 03/07/2023 | Buy Now | 79.06% | Wells Fargo | Stan Berenshteyn | $11 → $13 | Maintains | Equal-Weight | Get Alert |
| 03/02/2023 | Buy Now | 147.93% | Raymond James | John Ransom | $15 → $18 | Maintains | Strong Buy | Get Alert |
| 03/01/2023 | Buy Now | 106.61% | RBC Capital | Sean Dodge | $9 → $15 | Maintains | Sector Perform | Get Alert |
| 01/03/2023 | Buy Now | 51.52% | Evercore ISI Group | Elizabeth Anderson | $10 → $11 | Downgrade | Outperform → In-Line | Get Alert |
| 11/10/2022 | Buy Now | 106.61% | Raymond James | John Ransom | $20 → $15 | Maintains | Strong Buy | Get Alert |
| 11/09/2022 | Buy Now | 134.16% | SVB Leerink | Stephanie Davis | $20 → $17 | Maintains | Outperform | Get Alert |
| 10/31/2022 | Buy Now | 37.74% | Wells Fargo | Stan Berenshteyn | → $10 | Initiates | → Equal-Weight | Get Alert |
| 10/25/2022 | Buy Now | 23.97% | RBC Capital | Sean Dodge | $19 → $9 | Downgrade | Outperform → Sector Perform | Get Alert |
| 09/26/2022 | Buy Now | 189.26% | BTIG | David Larsen | $25 → $21 | Maintains | Buy | Get Alert |
| 09/16/2022 | Buy Now | — | Keybanc | Scott Schoenhaus | — | Initiates | → Sector Weight | Get Alert |
| 09/13/2022 | Buy Now | 51.52% | Piper Sandler | Jessica Tassan | $21 → $11 | Downgrade | Overweight → Neutral | Get Alert |
| 08/10/2022 | Buy Now | 147.93% | Goldman Sachs | Cindy Motz | $29 → $18 | Maintains | Buy | Get Alert |
| 08/09/2022 | Buy Now | 175.48% | Raymond James | John Ransom | $35 → $20 | Maintains | Strong Buy | Get Alert |
| 08/05/2022 | Buy Now | 120.39% | Stifel | David Grossman | $27 → $16 | Downgrade | Buy → Hold | Get Alert |
| 08/05/2022 | Buy Now | 120.39% | JP Morgan | Anne Samuel | $20 → $16 | Downgrade | Overweight → Neutral | Get Alert |
| 05/26/2022 | Buy Now | 409.64% | Goldman Sachs | Cindy Motz | $42 → $37 | Maintains | Buy | Get Alert |
| 05/11/2022 | Buy Now | 244.35% | Citigroup | Daniel Grosslight | $45 → $25 | Maintains | Buy | Get Alert |
| 05/11/2022 | Buy Now | 161.71% | RBC Capital | Sean Dodge | $35 → $19 | Maintains | Outperform | Get Alert |
| 05/11/2022 | Buy Now | 189.26% | Piper Sandler | Jessica Tassan | $38 → $21 | Maintains | Overweight | Get Alert |
| 05/11/2022 | Buy Now | 203.03% | SVB Leerink | Stephanie Davis | $48 → $22 | Maintains | Outperform | Get Alert |
| 04/14/2022 | Buy Now | 437.19% | Guggenheim | Jack Wallace | → $39 | Initiates | → Buy | Get Alert |
| 03/25/2022 | Buy Now | 588.71% | BTIG | David Larsen | $60 → $50 | Maintains | Buy | Get Alert |
| 03/17/2022 | Buy Now | 285.67% | Jefferies | Glen Santangelo | $31 → $28 | Upgrade | Hold → Buy | Get Alert |
| 03/07/2022 | Buy Now | 423.42% | Piper Sandler | Jessica Tassan | $66 → $38 | Maintains | Overweight | Get Alert |
| 03/04/2022 | Buy Now | 450.96% | Raymond James | John Ransom | $70 → $40 | Maintains | Strong Buy | Get Alert |
| 03/02/2022 | Buy Now | 382.09% | Canaccord Genuity | Richard Close | $62 → $35 | Maintains | Buy | Get Alert |
| 03/02/2022 | Buy Now | 382.09% | RBC Capital | Sean Dodge | $66 → $35 | Maintains | Outperform | Get Alert |
| 03/02/2022 | Buy Now | 561.16% | SVB Leerink | Stephanie Davis | $64 → $48 | Maintains | Outperform | Get Alert |
| 02/11/2022 | Buy Now | — | Goldman Sachs | Cindy Motz | — | Initiates | → Buy | Get Alert |
| 12/20/2021 | Buy Now | 657.58% | Citigroup | — | — | Maintains | Buy | Get Alert |
| 12/02/2021 | Buy Now | 561.16% | Jefferies | Glen Santangelo | — | Initiates | → Hold | Get Alert |
| 10/14/2021 | Buy Now | 726.45% | BTIG | David Larsen | — | Initiates | → Buy | Get Alert |
| 08/10/2021 | Buy Now | 864.19% | Raymond James | John Ransom | — | Maintains | Strong Buy | Get Alert |
| 08/09/2021 | Buy Now | 836.64% | Citigroup | Daniel Grosslight | — | Maintains | Buy | Get Alert |
| 08/06/2021 | Buy Now | 781.54% | SVB Leerink | Stephanie Davis | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Health Catalyst (HCAT) stock?
The latest price target for Health Catalyst (NASDAQ:HCAT) was reported by Evercore ISI Group on July 9, 2024. The analyst firm set a price target for $8.00 expecting HCAT to rise to within 12 months (a possible 10.19% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Health Catalyst (HCAT)?
The latest analyst rating for Health Catalyst (NASDAQ:HCAT) was provided by Evercore ISI Group, and Health Catalyst maintained their outperform rating.
When was the last upgrade for Health Catalyst (HCAT)?
The last upgrade for Health Catalyst Inc happened on January 26, 2024 when Guggenheim raised their price target to $14. Guggenheim previously had a neutral for Health Catalyst Inc.
When was the last downgrade for Health Catalyst (HCAT)?
The last downgrade for Health Catalyst Inc happened on April 10, 2024 when Keybanc changed their price target from N/A to N/A for Health Catalyst Inc.
When is the next analyst rating going to be posted or updated for Health Catalyst (HCAT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Health Catalyst, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Health Catalyst was filed on July 9, 2024 so you should expect the next rating to be made available sometime around July 9, 2025.
Is the Analyst Rating Health Catalyst (HCAT) correct?
While ratings are subjective and will change, the latest Health Catalyst (HCAT) rating was a maintained with a price target of $9.00 to $8.00. The current price Health Catalyst (HCAT) is trading at is $7.26, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.